DK0472706T3 - Induktion af beskyttelse mod viral infektion - Google Patents

Induktion af beskyttelse mod viral infektion

Info

Publication number
DK0472706T3
DK0472706T3 DK91906386.7T DK91906386T DK0472706T3 DK 0472706 T3 DK0472706 T3 DK 0472706T3 DK 91906386 T DK91906386 T DK 91906386T DK 0472706 T3 DK0472706 T3 DK 0472706T3
Authority
DK
Denmark
Prior art keywords
virus
induction
antibodies
protection against
viral infection
Prior art date
Application number
DK91906386.7T
Other languages
English (en)
Inventor
Marc Girard
Marie-Paule Kieny
Claude Leclerc
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0472706T3 publication Critical patent/DK0472706T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91906386.7T 1990-03-19 1991-03-16 Induktion af beskyttelse mod viral infektion DK0472706T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49474990A 1990-03-19 1990-03-19

Publications (1)

Publication Number Publication Date
DK0472706T3 true DK0472706T3 (da) 1997-12-29

Family

ID=23965805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91906386.7T DK0472706T3 (da) 1990-03-19 1991-03-16 Induktion af beskyttelse mod viral infektion

Country Status (10)

Country Link
EP (2) EP0472706B1 (da)
JP (2) JPH03271233A (da)
AT (1) ATE154244T1 (da)
AU (3) AU651816B2 (da)
CA (1) CA2057040A1 (da)
DE (1) DE69126486T2 (da)
DK (1) DK0472706T3 (da)
ES (1) ES2104695T3 (da)
GR (1) GR3024670T3 (da)
WO (1) WO1991014449A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
US5876724A (en) * 1990-03-19 1999-03-02 Institut Pasteur Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein
US6139843A (en) * 1991-04-02 2000-10-31 Albert Einstein College Of Medicine Of Yeshiva University Peptide compositions for the treatment of HIV
EP0536352B1 (en) * 1991-04-02 2003-12-17 Albert Einstein College Of Medicine Of Yeshiva University Therapeutic and preventive vaccines for hiv
EP0613378A1 (en) * 1991-10-28 1994-09-07 Institut Pasteur Induction of protection against viral infection by synergy between viral proteins and viral peptides
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
MX428176B (es) * 2019-01-28 2025-11-13 Xyphos Biosciences Inc Ligandos nkg2d no naturales modificados que entregan selectivamente moléculas heterólogas unidas a receptores nkg2d no naturales en células car.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2054616T3 (es) * 1985-12-17 1994-08-16 Akzo Nv Reactivo inmunoquimico.
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
DE3854550T2 (de) * 1987-11-24 1996-04-25 Abbott Lab HIV-Peptide und Methoden für den Nachweis von HIV.
US5039522A (en) * 1988-01-29 1991-08-13 New York Blood Center, Inc. Immunogens containing peptides with an attached hydrophobic tail for adsorption to hepatitis B virus surface antigen
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
FR2650954B1 (fr) * 1989-08-18 1992-02-28 Pasteur Institut Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida

Also Published As

Publication number Publication date
EP0472706B1 (en) 1997-06-11
EP0742229A3 (en) 1998-06-03
ES2104695T3 (es) 1997-10-16
CA2057040A1 (en) 1991-09-20
JPH03271233A (ja) 1991-12-03
EP0742229A2 (en) 1996-11-13
GR3024670T3 (en) 1997-12-31
EP0472706A1 (en) 1992-03-04
AU7498991A (en) 1991-10-21
AU6461594A (en) 1994-09-08
AU7196098A (en) 1998-08-13
ATE154244T1 (de) 1997-06-15
WO1991014449A1 (en) 1991-10-03
DE69126486D1 (de) 1997-07-17
DE69126486T2 (de) 1998-01-15
AU651816B2 (en) 1994-08-04
JPH04506220A (ja) 1992-10-29

Similar Documents

Publication Publication Date Title
EP0090581A3 (en) Small peptides with the specificity of foot and mouth disease viral antigens
DE69526339D1 (de) Monoklonale antikörper, die an den vorläufer des tumorabstossantigen mage-1 anbinden, rekombinantes mage-1, und von mage-1 abgebieteteimmunogene peptide
FI941199A0 (fi) Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset
DE69126301D1 (de) Hiv-induzierte synzytien blockierender anti-cd-4-antikörper
RU95122391A (ru) Адъюванты для вакцины против распираторно-синцитиального вируса
NO20012760D0 (no) HBV kjerneantigenpartikler med multiple immunogene komponenter bundet via peptidligander
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
GR3029264T3 (en) Anti-feline immunodeficiency virus (fiv) vaccines.
GR3024670T3 (en) Induction of protection against viral infection
ATE133708T1 (de) Immunogenisches peptid von echinococcus granulosis, dafür kodierende dns sowie diagnostische und therapeutische verwendungen
DK0714307T3 (da) Vaccinesammensætninger
DK0831881T3 (da) CETP til forøgelse af HDL-cholesterolniveau
DK0439601T3 (da) Præparat indeholdende en B-epitop fra kappe- glycoproteinet fra et retrovirus og en T-epitop fra et protein, der er forskelligt fra dette retrovirus
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
DK0470989T3 (da) Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer
SE9600436D0 (sv) Vaccine against hantavirus
DE69112392D1 (de) Bcrf1-antagonisten zur behandlung von epstein-barr-virus-infektionen.
RU93004854A (ru) Пептиды для вакцинации и индукции нейтрализующих антител против вируса иммунодефицита человека
KR970074790A (ko) 합성 펩티드를 함유하는 녹농균 백신 및 이것으로부터 생산된 치료제
CA2143187A1 (en) Anti-feline immunodeficiency virus (fiv) vaccines